Genetic variant in MTRR, but not MTR, is associated with risk of congenital heart disease: an integrated meta-analysis.

BACKGROUND: Congenital heart disease (CHD) is one of the most common birth defects and the leading cause of deaths among individuals with congenital structural abnormalities worldwide. Both Methionine synthase reductase (MTRR) and Methionine synthase (MTR) are key enzymes involved in the metabolic p...

Full description

Bibliographic Details
Main Authors: Bingxi Cai, Ti Zhang, Rong Zhong, Li Zou, Beibei Zhu, Wei Chen, Na Shen, Juntao Ke, Jiao Lou, Zhenling Wang, Yu Sun, Lifeng Liu, Ranran Song
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3942359?pdf=render
_version_ 1818925104743055360
author Bingxi Cai
Ti Zhang
Rong Zhong
Li Zou
Beibei Zhu
Wei Chen
Na Shen
Juntao Ke
Jiao Lou
Zhenling Wang
Yu Sun
Lifeng Liu
Ranran Song
author_facet Bingxi Cai
Ti Zhang
Rong Zhong
Li Zou
Beibei Zhu
Wei Chen
Na Shen
Juntao Ke
Jiao Lou
Zhenling Wang
Yu Sun
Lifeng Liu
Ranran Song
author_sort Bingxi Cai
collection DOAJ
description BACKGROUND: Congenital heart disease (CHD) is one of the most common birth defects and the leading cause of deaths among individuals with congenital structural abnormalities worldwide. Both Methionine synthase reductase (MTRR) and Methionine synthase (MTR) are key enzymes involved in the metabolic pathway of homocysteine, which are significant in the earlier period embryogenesis, particularly in the cardiac development. Evidence is mounting for the association between MTRR A66G (rs1801394)/MTR A2756G (rs1805087) and the CHD risk, but results are controversial. Therefore, we conducted a meta-analysis integrating case-control and transmitted disequilibrium test (TDT) studies to obtain more precise estimate of the associations of these two variants with the CHD risk. METHODS: To combine case-control and TDT studies, we used the Catmap package of R software to calculate odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: A total of 9 reports were included in the final meta-analysis. Eight of them comprised of 914 cases, 964 controls, and 441 families that were germane to MTRR A66G polymorphism; and 4 reports comprised of 250 cases, 205 controls, and 53 families that were relevant to MTR A2756G polymorphism. The pooled OR for the MTRR 66 G allele versus A allele was 1.35 (95% CI = 1.14-1.59, P<0.001, Pheterogeneity = 0.073). For MTR A2756G, the G allele conferred a pooled OR of 1.10 (95% CI = 0.78-1.57, P = 0.597, Pheterogeneity = 0.173) compared with the A allele. Sensitivity analyses were carried out to asses the effects of each individual study on the pooled OR, indicating the stability of the outcome. Moreover, positive results were also obtained in all subgroups stratified by study type and ethnicity except the subgroup of TDT studies in MTRR A66G variant. CONCLUSIONS: This meta-analysis demonstrated a suggestive result that the A66G variant in MTRR, but not the A2756G in MTR, may be associated with the increase of CHD risks.
first_indexed 2024-12-20T02:35:55Z
format Article
id doaj.art-1507392a641243c883abb96332a4281f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T02:35:55Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-1507392a641243c883abb96332a4281f2022-12-21T19:56:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0193e8960910.1371/journal.pone.0089609Genetic variant in MTRR, but not MTR, is associated with risk of congenital heart disease: an integrated meta-analysis.Bingxi CaiTi ZhangRong ZhongLi ZouBeibei ZhuWei ChenNa ShenJuntao KeJiao LouZhenling WangYu SunLifeng LiuRanran SongBACKGROUND: Congenital heart disease (CHD) is one of the most common birth defects and the leading cause of deaths among individuals with congenital structural abnormalities worldwide. Both Methionine synthase reductase (MTRR) and Methionine synthase (MTR) are key enzymes involved in the metabolic pathway of homocysteine, which are significant in the earlier period embryogenesis, particularly in the cardiac development. Evidence is mounting for the association between MTRR A66G (rs1801394)/MTR A2756G (rs1805087) and the CHD risk, but results are controversial. Therefore, we conducted a meta-analysis integrating case-control and transmitted disequilibrium test (TDT) studies to obtain more precise estimate of the associations of these two variants with the CHD risk. METHODS: To combine case-control and TDT studies, we used the Catmap package of R software to calculate odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: A total of 9 reports were included in the final meta-analysis. Eight of them comprised of 914 cases, 964 controls, and 441 families that were germane to MTRR A66G polymorphism; and 4 reports comprised of 250 cases, 205 controls, and 53 families that were relevant to MTR A2756G polymorphism. The pooled OR for the MTRR 66 G allele versus A allele was 1.35 (95% CI = 1.14-1.59, P<0.001, Pheterogeneity = 0.073). For MTR A2756G, the G allele conferred a pooled OR of 1.10 (95% CI = 0.78-1.57, P = 0.597, Pheterogeneity = 0.173) compared with the A allele. Sensitivity analyses were carried out to asses the effects of each individual study on the pooled OR, indicating the stability of the outcome. Moreover, positive results were also obtained in all subgroups stratified by study type and ethnicity except the subgroup of TDT studies in MTRR A66G variant. CONCLUSIONS: This meta-analysis demonstrated a suggestive result that the A66G variant in MTRR, but not the A2756G in MTR, may be associated with the increase of CHD risks.http://europepmc.org/articles/PMC3942359?pdf=render
spellingShingle Bingxi Cai
Ti Zhang
Rong Zhong
Li Zou
Beibei Zhu
Wei Chen
Na Shen
Juntao Ke
Jiao Lou
Zhenling Wang
Yu Sun
Lifeng Liu
Ranran Song
Genetic variant in MTRR, but not MTR, is associated with risk of congenital heart disease: an integrated meta-analysis.
PLoS ONE
title Genetic variant in MTRR, but not MTR, is associated with risk of congenital heart disease: an integrated meta-analysis.
title_full Genetic variant in MTRR, but not MTR, is associated with risk of congenital heart disease: an integrated meta-analysis.
title_fullStr Genetic variant in MTRR, but not MTR, is associated with risk of congenital heart disease: an integrated meta-analysis.
title_full_unstemmed Genetic variant in MTRR, but not MTR, is associated with risk of congenital heart disease: an integrated meta-analysis.
title_short Genetic variant in MTRR, but not MTR, is associated with risk of congenital heart disease: an integrated meta-analysis.
title_sort genetic variant in mtrr but not mtr is associated with risk of congenital heart disease an integrated meta analysis
url http://europepmc.org/articles/PMC3942359?pdf=render
work_keys_str_mv AT bingxicai geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis
AT tizhang geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis
AT rongzhong geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis
AT lizou geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis
AT beibeizhu geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis
AT weichen geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis
AT nashen geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis
AT juntaoke geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis
AT jiaolou geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis
AT zhenlingwang geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis
AT yusun geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis
AT lifengliu geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis
AT ranransong geneticvariantinmtrrbutnotmtrisassociatedwithriskofcongenitalheartdiseaseanintegratedmetaanalysis